Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,957 | Dovepress* | 6,080+ | 157 | 6,237 | |
| PubMed Central* | 1,877 | 447 | 2,324 | ||
| Totals | 7,957 | 604 | 8,561 | ||
| *Since 6 October 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar